{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:27:35Z","timestamp":1792009655491,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Patient-Centered Clinical Research Coordinating Center"},{"name":"Korea Health Technology R&D Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-56521-6","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:35:11Z","timestamp":1781325311000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Steroid administration, timing, and dose in patients with septic shock in the emergency department: retrospective analysis of a multicenter prospective cohort study"],"prefix":"10.1038","volume":"16","author":[{"given":"Sejoong","family":"Ahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiwon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Yeon","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hak","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Joon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woon Yong","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taeyoung","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Phil","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byuk Sung","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Ho","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Gun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyuseok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Korean Shock Society","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyo Jin","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Sung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhyun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Joon","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"You Hwan","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Jai","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangsoo","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heewon","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoo Seok","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Joon","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"issue":"8","key":"56521_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer, M. et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315 (8), 801\u2013810. https:\/\/doi.org\/10.1001\/jama.2016.0287 (2016).","journal-title":"JAMA"},{"issue":"11","key":"56521_CR2","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans, L. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 47 (11), 1181\u20131247. https:\/\/doi.org\/10.1007\/s00134-021-06506-y (2021).","journal-title":"Intensive Care Med."},{"issue":"11","key":"56521_CR3","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans, L. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit. Care Med. 49 (11), e1063\u2013e1143. https:\/\/doi.org\/10.1097\/CCM.0000000000005337 (2021).","journal-title":"Crit. Care Med."},{"issue":"12","key":"56521_CR4","doi-asserted-by":"publisher","first-page":"e2013","DOI":"10.1016\/S2214-109X(25)00356-0","volume":"13","author":"GBD 2021 Global Sepsis Collaborators","year":"2025","unstructured":"GBD 2021 Global Sepsis Collaborators. Global, regional, and national sepsis incidence and mortality, 1990\u20132021: a systematic analysis. Lancet Glob. Health. 13 (12), e2013\u2013e2026. https:\/\/doi.org\/10.1016\/S2214-109X(25)00356-0 (2025).","journal-title":"Lancet Glob. Health"},{"issue":"3","key":"56521_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.15441\/ceem.25.174","volume":"12","author":"TG Shin","year":"2025","unstructured":"Shin, T. G., Ko, E., Han, S. H., Kim, T. & Choi, D. H. Epidemiology of sepsis in emergency departments: insights from the National Emergency Department Information System (NEDIS) database in Korea, 2018\u20132022. Clin. Exp. Emerg. Med. 12 (3), 185\u2013187. https:\/\/doi.org\/10.15441\/ceem.25.174 (2025).","journal-title":"Clin. Exp. Emerg. Med."},{"issue":"4","key":"56521_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nri.2017.1","volume":"17","author":"DW Cain","year":"2017","unstructured":"Cain, D. W. & Cidlowski, J. A. Immune regulation by glucocorticoids. Nat. Rev. Immunol. 17 (4), 233\u2013247. https:\/\/doi.org\/10.1038\/nri.2017.1 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"56521_CR7","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.3389\/fimmu.2018.01736","volume":"9","author":"N Heming","year":"2018","unstructured":"Heming, N., Sivanandamoorthy, S., Meng, P., Bounab, R. & Annane, D. immune effects of corticosteroids in sepsis. Front. Immunol. 9, 1736. https:\/\/doi.org\/10.3389\/fimmu.2018.01736 (2018). Published 2018 Jul 30.","journal-title":"Front. Immunol."},{"issue":"7","key":"56521_CR8","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1001\/jama.288.7.862","volume":"288","author":"D Annane","year":"2002","unstructured":"Annane, D. et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (7), 862\u2013871. https:\/\/doi.org\/10.1001\/jama.288.7.862 (2002).","journal-title":"JAMA"},{"issue":"2","key":"56521_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa071366","volume":"358","author":"CL Sprung","year":"2008","unstructured":"Sprung, C. L. et al. Hydrocortisone therapy for patients with septic shock. N Engl. J. Med. 358 (2), 111\u2013124. https:\/\/doi.org\/10.1056\/NEJMoa071366 (2008).","journal-title":"N Engl. J. Med."},{"issue":"9","key":"56521_CR10","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1056\/NEJMoa1705716","volume":"378","author":"D Annane","year":"2018","unstructured":"Annane, D. et al. Hydrocortisone plus fludrocortisone for adults with septic shock. N Engl. J. Med. 378 (9), 809\u2013818. https:\/\/doi.org\/10.1056\/NEJMoa1705716 (2018).","journal-title":"N Engl. J. Med."},{"issue":"9","key":"56521_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1056\/NEJMoa1705835","volume":"378","author":"B Venkatesh","year":"2018","unstructured":"Venkatesh, B. et al. Adjunctive glucocorticoid therapy in patients with septic shock. N Engl. J. Med. 378 (9), 797\u2013808. https:\/\/doi.org\/10.1056\/NEJMoa1705835 (2018).","journal-title":"N Engl. J. Med."},{"issue":"7","key":"56521_CR12","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","volume":"44","author":"SL Ryg\u00e5rd","year":"2018","unstructured":"Ryg\u00e5rd, S. L. et al. Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysis. Intensive Care Med. 44 (7), 1003\u20131016. https:\/\/doi.org\/10.1007\/s00134-018-5197-6 (2018).","journal-title":"Intensive Care Med."},{"issue":"12","key":"56521_CR13","doi-asserted-by":"publisher","first-page":"CD002243","DOI":"10.1002\/14651858.CD002243.pub4","volume":"12","author":"D Annane","year":"2019","unstructured":"Annane, D. et al. Corticosteroids for treating sepsis in children and adults. Cochrane Database Syst. Rev. 12 (12), CD002243. https:\/\/doi.org\/10.1002\/14651858.CD002243.pub4 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"56521_CR14","doi-asserted-by":"publisher","first-page":"709155","DOI":"10.3389\/fimmu.2021.709155","volume":"12","author":"H Liang","year":"2021","unstructured":"Liang, H. et al. Corticosteroids for treating sepsis in adult patients: a systematic review and meta-analysis. Front. Immunol. 12, 709155. https:\/\/doi.org\/10.3389\/fimmu.2021.709155 (2021).","journal-title":"Front. Immunol."},{"issue":"6","key":"56521_CR15","doi-asserted-by":"publisher","first-page":"EVIDoa2300034","DOI":"10.1056\/EVIDoa230003","volume":"2","author":"R Pirracchio","year":"2023","unstructured":"Pirracchio, R. et al. Patient-level meta-analysis of low-dose hydrocortisone in adults with septic shock. NEJM Evid. 2 (6), EVIDoa2300034. https:\/\/doi.org\/10.1056\/EVIDoa230003 (2023).","journal-title":"NEJM Evid."},{"issue":"1","key":"56521_CR16","doi-asserted-by":"publisher","first-page":"e1000","DOI":"10.1097\/CCE.0000000000001000","volume":"6","author":"T Pitre","year":"2024","unstructured":"Pitre, T. et al. Corticosteroids in sepsis and septic shock: a systematic review, pairwise, and dose-response meta-analysis. Crit. Care Explor. 6 (1), e1000. https:\/\/doi.org\/10.1097\/CCE.0000000000001000 (2024).","journal-title":"Crit. Care Explor."},{"issue":"6","key":"56521_CR17","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1097\/CCM.0000000000000212","volume":"42","author":"AC Gordon","year":"2014","unstructured":"Gordon, A. C. et al. The interaction of vasopressin and corticosteroids in septic shock: a pilot randomized controlled trial. Crit. Care Med. 42 (6), 1325\u20131333. https:\/\/doi.org\/10.1097\/CCM.0000000000000212 (2014).","journal-title":"Crit. Care Med."},{"issue":"5","key":"56521_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1001\/jama.2016.10485","volume":"316","author":"AC Gordon","year":"2016","unstructured":"Gordon, A. C. et al. Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH Randomized Clinical Trial. JAMA 316 (5), 509\u2013518. https:\/\/doi.org\/10.1001\/jama.2016.10485 (2016).","journal-title":"JAMA"},{"issue":"1","key":"56521_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.15441\/ceem.24.351","volume":"12","author":"G Oliva","year":"2025","unstructured":"Oliva, G. & Ulloa, N. Vasopressin: a review of clinical indications. Clin. Exp. Emerg. Med. 12 (1), 94\u201396. https:\/\/doi.org\/10.15441\/ceem.24.351 (2025).","journal-title":"Clin. Exp. Emerg. Med."},{"issue":"3","key":"56521_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/01.shk.0000235140.97903.90","volume":"27","author":"C Ertmer","year":"2007","unstructured":"Ertmer, C. et al. Methylprednisolone reverses vasopressin hyporesponsiveness in ovine endotoxemia. Shock 27 (3), 281\u2013288. https:\/\/doi.org\/10.1097\/01.shk.0000235140.97903.90 (2007).","journal-title":"Shock"},{"issue":"3","key":"56521_CR21","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/CCM.0b013e3181961ace","volume":"37","author":"JA Russell","year":"2009","unstructured":"Russell, J. A. et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit. Care Med. 37 (3), 811\u2013818. https:\/\/doi.org\/10.1097\/CCM.0b013e3181961ace (2009).","journal-title":"Crit. Care Med."},{"issue":"8","key":"56521_CR22","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1164\/rccm.201807-1419OC","volume":"199","author":"DB Antcliffe","year":"2019","unstructured":"Antcliffe, D. B. et al. Transcriptomic signatures in sepsis and a differential response to steroids. From the VANISH Randomized Trial. Am. J. Respir. Crit. Care Med. 199 (8), 980\u2013986. https:\/\/doi.org\/10.1164\/rccm.201807-1419OC (2019).","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"56521_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s13054-025-05540-2","volume":"29","author":"Q Lajoye","year":"2025","unstructured":"Lajoye, Q., Orieux, A., Boyer, A., Prevel, R. & Jozwiak, M. Vasopressin and its analogues in patients with septic shock: holy Grail or unfulfilled promise? Crit. Care. 29 (1), 333. https:\/\/doi.org\/10.1186\/s13054-025-05540-2 (2025).","journal-title":"Crit. Care"},{"issue":"5","key":"56521_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1177\/10600280231191131","volume":"58","author":"AM Alshehri","year":"2024","unstructured":"Alshehri, A. M., Kovacevic, M. P., Dube, K. M., Lupi, K. E. & DeGrado, J. R. Comparison of early versus late adjunctive vasopressin and corticosteroids in patients with septic shock. Ann. Pharmacother. 58 (5), 461\u2013468. https:\/\/doi.org\/10.1177\/10600280231191131 (2024).","journal-title":"Ann. Pharmacother."},{"key":"56521_CR25","doi-asserted-by":"publisher","unstructured":"You, J. S. et al. Relationship between time of emergency department admission and adherence to the Surviving Sepsis Campaign bundle in patients with septic shock. Crit. Care 26 (1), 43.  https:\/\/doi.org\/10.1186\/s13054-022-03899-0   (2022).","DOI":"10.1186\/s13054-022-03899-0"},{"issue":"1","key":"56521_CR26","doi-asserted-by":"publisher","first-page":"4900","DOI":"10.1038\/s41598-024-55421-x","volume":"14","author":"S Ahn","year":"2024","unstructured":"Ahn, S. et al. Sex differences in in-hospital management in patients with sepsis and septic shock: a prospective multicenter observational study. Sci. Rep. 14 (1), 4900. https:\/\/doi.org\/10.1038\/s41598-024-55421-x (2024). Published 2024 Feb 28.","journal-title":"Sci. Rep."},{"key":"56521_CR27","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent, J. L. et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 22, 707\u2013710. https:\/\/doi.org\/10.1007\/BF01709751 (1996).","journal-title":"Intensive Care Med."},{"issue":"4","key":"56521_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.15441\/ceem.24.330","volume":"11","author":"TG Shin","year":"2024","unstructured":"Shin, T. G. Assessment of organ failure in sepsis patients in the emergency department: clinical evaluation, Sequential Organ Failure Assessment (SOFA) score, and future perspectives. Clin. Exp. Emerg. Med. 11 (4), 327\u2013330. https:\/\/doi.org\/10.15441\/ceem.24.330 (2024).","journal-title":"Clin. Exp. Emerg. Med."},{"key":"56521_CR29","doi-asserted-by":"publisher","unstructured":"Kotani, Y., Di Gioia, A., Landoni, G., Belletti, A. & Khanna, A. K. An updated norepinephrine equivalent score in intensive care as a marker of shock severity. Crit. Care 27 (1), 29.  https:\/\/doi.org\/10.1186\/s13054-023-04322-y    (2023).","DOI":"10.1186\/s13054-023-04322-y"},{"key":"56521_CR30","doi-asserted-by":"publisher","unstructured":"Ammar, M. A. et al. Timing of vasoactive agents and corticosteroid initiation in septic shock. Ann. Intensive Care 12 (1), 47. https:\/\/doi.org\/10.1186\/s13613-022-01021-9 (2022).","DOI":"10.1186\/s13613-022-01021-9"},{"issue":"4","key":"56521_CR31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/SHK.0000000000001651","volume":"55","author":"GL Sacha","year":"2021","unstructured":"Sacha, G. L., Chen, A. Y., Palm, N. M. & Duggal, A. Evaluation of the initiation timing of hydrocortisone in adult patients with septic shock. Shock 55 (4), 488\u2013494. https:\/\/doi.org\/10.1097\/SHK.0000000000001651 (2021).","journal-title":"Shock"},{"issue":"3","key":"56521_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/10600280211021103","volume":"56","author":"D Ragoonanan","year":"2022","unstructured":"Ragoonanan, D., Allen, B., Cannon, C., Rottman-Pietrzak, K. & Bello, A. Comparison of early versus late initiation of hydrocortisone in patients with septic shock in the ICU setting. Ann. Pharmacother. 56 (3), 264\u2013270. https:\/\/doi.org\/10.1177\/10600280211021103 (2022).","journal-title":"Ann. Pharmacother."},{"key":"56521_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v045.i03","volume":"45","author":"S van Buuren","year":"2011","unstructured":"van Buuren, S. & Groothuis-Oudshoorn, K. Mice: multivariate imputation by chained equations in R. J. Stat. Softw. 45, 1\u201367. https:\/\/doi.org\/10.18637\/jss.v045.i03 (2011).","journal-title":"J. Stat. Softw."},{"issue":"4","key":"56521_CR34","doi-asserted-by":"publisher","first-page":"R979","DOI":"10.1152\/ajpregu.00520.2001","volume":"282","author":"M Bucher","year":"2002","unstructured":"Bucher, M., Hobbhahn, J., Taeger, K. & Kurtz, A. Cytokine-mediated downregulation of vasopressin V(1A) receptors during acute endotoxemia in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 282 (4), R979\u2013R984. https:\/\/doi.org\/10.1152\/ajpregu.00520.2001 (2002).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"2 Pt 2","key":"56521_CR35","doi-asserted-by":"publisher","first-page":"I42","DOI":"10.1161\/01.hyp.11.2_pt_2.i42","volume":"11","author":"F Iijima","year":"1988","unstructured":"Iijima, F. & Malik, K. U. Contribution of vasopressin in dexamethasone-induced hypertension in rats. Hypertension 11 (2 Pt 2), I42\u2013I46. https:\/\/doi.org\/10.1161\/01.hyp.11.2_pt_2.i42 (1988).","journal-title":"Hypertension"},{"issue":"4","key":"56521_CR36","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/01.hyp.26.4.665","volume":"26","author":"S Murasawa","year":"1995","unstructured":"Murasawa, S. et al. Glucocorticoids regulate V1a vasopressin receptor expression by increasing mRNA stability in vascular smooth muscle cells. Hypertension 26 (4), 665\u2013669. https:\/\/doi.org\/10.1161\/01.hyp.26.4.665 (1995).","journal-title":"Hypertension"},{"issue":"5","key":"56521_CR37","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1210\/endo.140.5.6718","volume":"140","author":"K Katsuyama","year":"1999","unstructured":"Katsuyama, K. et al. Differential inhibitory actions by glucocorticoid and aspirin on cytokine-induced nitric oxide production in vascular smooth muscle cells. Endocrinology 140 (5), 2183\u20132190. https:\/\/doi.org\/10.1210\/endo.140.5.6718 (1999).","journal-title":"Endocrinology"},{"issue":"6","key":"56521_CR38","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1210\/endo-129-6-2845","volume":"129","author":"M Thibonnier","year":"1991","unstructured":"Thibonnier, M., Bayer, A. L., Simonson, M. S. & Kester, M. Multiple signaling pathways of V1-vascular vasopressin receptors of A7r5 cells. Endocrinology 129 (6), 2845\u20132856. https:\/\/doi.org\/10.1210\/endo-129-6-2845 (1991).","journal-title":"Endocrinology"},{"issue":"12","key":"56521_CR39","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/nri3552","volume":"13","author":"RS Hotchkiss","year":"2013","unstructured":"Hotchkiss, R. S., Monneret, G. & Payen, D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nat. Rev. Immunol. 13 (12), 862\u2013874. https:\/\/doi.org\/10.1038\/nri3552 (2013).","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"56521_CR40","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/bcpt.13645","volume":"129","author":"RH Skauby","year":"2021","unstructured":"Skauby, R. H., Bergan, S., Andersen, A. M., Vethe, N. T. & Christensen, H. In vitro assessments predict that CYP3A4 contributes to a greater extent than CYP3A5 to prednisolone clearance. Basic. Clin. Pharmacol. Toxicol. 129 (6), 427\u2013436. https:\/\/doi.org\/10.1111\/bcpt.13645 (2021).","journal-title":"Basic. Clin. Pharmacol. Toxicol."},{"issue":"5\u20136","key":"56521_CR41","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41397-022-00288-2","volume":"22","author":"Y Zhou","year":"2022","unstructured":"Zhou, Y. & Lauschke, V. M. The genetic landscape of major drug metabolizing cytochrome P450 genes-an updated analysis of population-scale sequencing data. Pharmacogenomics J. 22 (5\u20136), 284\u2013293. https:\/\/doi.org\/10.1038\/s41397-022-00288-2 (2022).","journal-title":"Pharmacogenomics J."},{"issue":"1","key":"56521_CR42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13054-019-2313-0","volume":"23","author":"H Lu","year":"2019","unstructured":"Lu, H. et al. Host genetic variants in sepsis risk: a field synopsis and meta-analysis. Crit. Care. 23 (1), 26. https:\/\/doi.org\/10.1186\/s13054-019-2313-0 (2019).","journal-title":"Crit. Care"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56521-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56521-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56521-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:06:12Z","timestamp":1787789172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-56521-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["56521"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-56521-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Institutional Review Board of the Korea University Ansan Hospital (2025AS0150), which waived the requirement for informed consent due to the nature of the observational study.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"26929"}}